Moderna lifts 2026 growth outlook to 15–25% after 29% Q3 jump
Moderna’s third-quarter revenue rose 29% to $1.313 billion, up from $1.016 billion a year earlier. It swung to a net profit of $162 million, against a loss of $200 million in Q3 2025. Diluted EPS was $0.38, compared with a $0.51 loss. US sales were $78…